Latest News about CLDX
Recent news which mentions CLDX
From Benzinga
From Benzinga
From Benzinga
Why Celldex Therapeutics Shares Are Trading Higher Today
February 27, 2023
Tickers
CLDX
From Benzinga
These '20 Stocks To Watch' Moved On Last Fed Rate Hike: How Will They React Today?
February 01, 2023
From Benzinga
Celldex Therapeutics Earnings Perspective: Return On Capital Employed
December 19, 2022
Tickers
CLDX
From Benzinga
BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
December 13, 2022
From Benzinga
From Benzinga
HC Wainwright & Co. Maintains Buy Rating for Celldex Therapeutics: Here's What You Need To Know
July 01, 2022
Tickers
CLDX
From Benzinga
Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
July 01, 2022
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 02, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
June 01, 2022
From Benzinga
77 Biggest Movers From Yesterday
June 01, 2022
From Benzinga
From InvestorPlace
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 15, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 17, 2021
September 17, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021
September 10, 2021
From Benzinga
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
From Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
